Shanghai Rendu Biotechnology Co. Ltd. A (688193.SS) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · China · ISIN CNE1000059K5

Price
45.19 CNY
Market cap
1.81 bn CNY
P/E (2025)
179.51
P/S (2025)
11.18
Dividend yield
0.33 %
Net margin
6.23 %
Return on equity (ROE)
1.10 %
Return on assets (ROA)
1.02 %

Shanghai Rendu Biotechnology Co. Ltd. A financials

Fiscal year20242025
Revenue177.35 m CNY161.94 m CNY
Gross profit140.97 m CNY126.38 m CNY
Operating income-12.09 m CNY-14.27 m CNY
EBIT-14.93 m CNY10.46 m CNY
Net income-7.81 m CNY10.09 m CNY
Diluted EPS – continuing operations-0.20 CNY0.25 CNY

Full history since 2019, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Shanghai Rendu Biotechnology Co. Ltd. A

Shanghai Rendu Biotechnology Co., Ltd. engages in the research, development, production, and sales of molecular diagnostic reagents products and supporting equipment in China and internationally. Its products are used in various therapeutic areas, including reproductive tract, respiratory tract, enterovirus infections, and bloodborne infectious diseases, as well as tumor auxiliary diagnosis. The company was founded in 2007 and is based in Shanghai, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.